| Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness J Cai, H Tang, L Xu, X Wang, C Yang, S Ruan, J Guo, S Hu, Z Wang Carcinogenesis 33 (1), 20-29, 2012 | 211 | 2012 |
| Clinical features and short-term outcomes of elderly patients with COVID-19 P Li, L Chen, Z Liu, J Pan, D Zhou, H Wang, H Gong, Z Fu, Q Song, Q Min, ... International Journal of Infectious Diseases 97, 245-250, 2020 | 128 | 2020 |
| OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers T Wang, S Ruan, X Zhao, X Shi, H Teng, J Zhong, M You, K Xia, Z Sun, ... Nucleic acids research 49 (D1), D1289-D1301, 2021 | 83 | 2021 |
| Integrin β4–targeted cancer immunotherapies inhibit tumor growth and decrease metastasis S Ruan, M Lin, Y Zhu, L Lum, A Thakur, R Jin, W Shao, Y Zhang, Y Hu, ... Cancer research 80 (4), 771-783, 2020 | 68 | 2020 |
| OncoBase: a platform for decoding regulatory somatic mutations in human cancers X Li, L Shi, Y Wang, J Zhong, X Zhao, H Teng, X Shi, H Yang, S Ruan, ... Nucleic Acids Research 47 (D1), D1044-D1055, 2019 | 45 | 2019 |
| CircleBase: an integrated resource and analysis platform for human eccDNAs X Zhao, L Shi, S Ruan, W Bi, Y Chen, L Chen, Y Liu, M Li, J Qiao, F Mao Nucleic acids research 50 (D1), D72-D82, 2022 | 33 | 2022 |
| Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses G Li, S Ruan, X Zhao, Q Liu, Y Dou, F Mao Computational and Structural Biotechnology Journal 19, 1-15, 2021 | 27 | 2021 |
| Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic W Zhao, H Qiu, Y Gong, C Han, S Ruan, C Wang, J Chen, S Ke, W Shi, ... American Journal of Cancer Research 10 (8), 2282, 2020 | 9 | 2020 |
| Targeting cancer stem cells via integrin β4 HE Dobson, S Ruan, AE Chang, MS Wicha, Q Li Oncotarget 12 (18), 1850, 2021 | 8 | 2021 |
| A phase 2 trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocelluar carcinoma. S Ke, H Qiu, J Peng, G Cai, Y Zhangcai, H Cheng, Y Cai, L Xia, X Luo, ... Journal of Clinical Oncology 39 (15_suppl), e16136-e16136, 2021 | | 2021 |
| Transcriptomic Signatures and Immunomodulatory Treatments for COVID-19 Patients G Li, X Zhao, Q Liu, S Ruan, Y Dou, F Mao | | 2020 |
| Integrin β4-targeted cancer immunotherapies S Ruan, M Lin, Y Chen, E Hurt, AE Chang, MS Wicha, Q Li Cancer Research 79 (13_Supplement), 375-375, 2019 | | 2019 |
